Figure 11.

Effects of PS treatments on the plasma total cholesterol, 17β-estradiol, and CA 15-3 levels in BT-474 tumors in HFD fed nude mice. (A) Comparison of the mean plasma total cholesterol levels of PS-treated versus vehicle control-treated in BT-474 tumors at the experiment end. (B) Comparison of the 17β-estradiol plasma levels of PS versus vehicle control-treated nude mice xenografted BT-474 tumor cells at the experiment end. (C) Comparison of the BC recurrence marker CA 15-3 plasma levels of PS versus vehicle control-treated nude mice xenografted BT-474 tumor cells at the experiment end. p>0.05 is statistically not significant.